Tumour cell density quantified by artificial intelligence is associated with differential benefit from irinotecan-based chemo-radiotherapy in locally advanced rectal cancer: a post-hoc study of the phase 3 ARISTOTLE trial
Zhuoyan Shen, Douglas Brand, Mikaël Simard, Nicholas P. West et autres